Cogent Biosciences (COGT) Profit After Tax (2017 - 2020)
Historic Profit After Tax for Cogent Biosciences (COGT) over the last 4 years, with Q4 2020 value amounting to -$11.3 million.
- Cogent Biosciences' Profit After Tax fell 59360.03% to -$11.3 million in Q4 2020 from the same period last year, while for Dec 2020 it was -$74.8 million, marking a year-over-year decrease of 13500.14%. This contributed to the annual value of -$74.8 million for FY2020, which is 13500.14% down from last year.
- Latest data reveals that Cogent Biosciences reported Profit After Tax of -$11.3 million as of Q4 2020, which was down 59360.03% from -$50.0 million recorded in Q3 2020.
- Cogent Biosciences' 5-year Profit After Tax high stood at $2.3 million for Q4 2019, and its period low was -$50.0 million during Q3 2020.
- For the 4-year period, Cogent Biosciences' Profit After Tax averaged around -$10.4 million, with its median value being -$8.0 million (2018).
- As far as peak fluctuations go, Cogent Biosciences' Profit After Tax surged by 12669.07% in 2019, and later tumbled by 59360.03% in 2020.
- Cogent Biosciences' Profit After Tax (Quarter) stood at -$6.7 million in 2017, then decreased by 28.64% to -$8.6 million in 2018, then skyrocketed by 126.69% to $2.3 million in 2019, then tumbled by 593.6% to -$11.3 million in 2020.
- Its Profit After Tax stands at -$11.3 million for Q4 2020, versus -$50.0 million for Q3 2020 and -$7.4 million for Q2 2020.